<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Adenoviruses News</title>
<link>http://www.inboxrobot.com/news/adenoviruses</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>Crucell wins NIAID/NIH contract for development of filovirus vaccine</title>
<link>http://www.inboxrobot.com/news.php?fid=191835530</link>
<pubDate>7 Oct 2008 05:53 GMT</pubDate>
<description>
...  of Crucell&apos;s proprietary AdVac technology. This award recognizes the scientific basis for using rare adenovirus serotypes to develop vaccines.&quot; &quot;The contract builds upon earlier work Crucell has performed with  ...
</description>
</item><item>
<title>The cold war</title>
<link>http://www.inboxrobot.com/news.php?fid=191826968</link>
<pubDate>7 Oct 2008 04:55 GMT</pubDate>
<description>
...  a half of colds are caused by rhinoviruses. Others are coronaviruses, respiratory syncytial virus, adenovirus and influenza virus. All the viruses have very similar effects and there is no  ...
</description>
</item><item>
<title>FranTech Asia licensing Munogenics, Inc.</title>
<link>http://www.inboxrobot.com/news.php?fid=191763254</link>
<pubDate>6 Oct 2008 23:34 GMT</pubDate>
<description>
...  Sciences, Medical Center (&quot;WFUHS&quot;) new cancer treatments technology for research in the field of adenovirus-based gene delivery for cancer treatment. Munogenics has also obtained an option for a non-exclusive  ...
</description>
</item><item>
<title>NanoViricides, Inc. to File Annual Report Shortly; Discusses Status of Current Projects</title>
<link>http://www.inboxrobot.com/news.php?fid=191708017</link>
<pubDate>6 Oct 2008 19:19 GMT</pubDate>
<description>
...  financing, we are now busy scheduling the follow-on studies against HIV as well as adenoviral EKC. We have received significant interest from several major pharmaceutical companies, as well as  ...
</description>
</item><item>
<title>NanoViricides, Inc. to File Annual Report Shortly; Discusses Status of Current Projects Temporary Stock Symbol Change Will Be Reversed</title>
<link>http://www.inboxrobot.com/news.php?fid=191707769</link>
<pubDate>6 Oct 2008 19:18 GMT</pubDate>
<description>
...  financing, we are now busy scheduling the follow-on studies against HIV as well as adenoviral EKC. We have received significant interest from several major pharmaceutical companies, as well as  ...
</description>
</item><item>
<title>Researchers create stem cells that lower risk of cancer-causing side effects</title>
<link>http://www.inboxrobot.com/news.php?fid=191698067</link>
<pubDate>6 Oct 2008 18:28 GMT</pubDate>
<description>
...  the Harvard Stem Cell Institute successfully created mouse-induced pluripotent stem (iPS) cells by using adenoviruses, instead of retroviruses as used in experiments by Professor Shinya Yamanaka at Kyoto University  ...
</description>
</item><item>
<title>--&gt; Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines</title>
<link>http://www.inboxrobot.com/news.php?fid=191325265</link>
<pubDate>4 Oct 2008 00:06 GMT</pubDate>
<description>
...  Goudsmit, Crucell&apos;s Chief Scientific Officer. &quot;This award recognizes the scientific basis for using rare adenovirus serotypes to develop vaccines.&quot; Dr. Goudsmit added, &quot;The contract builds upon earlier work Crucell  ...
</description>
</item><item>
<title>Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines</title>
<link>http://www.inboxrobot.com/news.php?fid=191322839</link>
<pubDate>3 Oct 2008 23:36 GMT</pubDate>
<description>
...  Goudsmit, Crucell&apos;s Chief Scientific Officer. &quot;This award recognizes the scientific basis for using rare adenovirus serotypes to develop vaccines.&quot; Dr. Goudsmit added, &quot;The contract builds upon earlier work Crucell  ...
</description>
</item><item>
<title>Losing common ground</title>
<link>http://www.inboxrobot.com/news.php?fid=191258455</link>
<pubDate>3 Oct 2008 06:55 GMT</pubDate>
<description>
 ...
</description>
</item></channel>
</rss>
